Marinus Pharmaceuticals (LTS:0JYL) Change In Prepaid Assets : $2.56 Mil (TTM As of Sep. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Marinus Pharmaceuticals Change In Prepaid Assets?

Marinus Pharmaceuticals's Change In Prepaid Assets for the quarter that ended in Sep. 2024 was $1.99 Mil. It means Marinus Pharmaceuticals's Prepaid Assets increased by $1.99 Mil from Jun. 2024 to Sep. 2024 .

Marinus Pharmaceuticals's Change In Prepaid Assets for the fiscal year that ended in Dec. 2023 was $-2.55 Mil. It means Marinus Pharmaceuticals's Prepaid Assets declined by $2.55 Mil from Dec. 2022 to Dec. 2023 .

Marinus Pharmaceuticals Change In Prepaid Assets Historical Data

The historical data trend for Marinus Pharmaceuticals's Change In Prepaid Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Marinus Pharmaceuticals Change In Prepaid Assets Chart

Marinus Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Prepaid Assets

Get a 7-Day Free Trial

-1.48

-3.92

-0.85

-5.58

-2.55

Marinus Pharmaceuticals Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Change In Prepaid Assets	Get a 7-Day Free Trial															1.15	3.74	-3.83	0.67	1.99

Marinus Pharmaceuticals Change In Prepaid Assets Calculation

Change In Prepaid Assets is any increase or decrease between periods of the prepaid assets.

Change In Prepaid Assets for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.56 Mil.

Marinus Pharmaceuticals Change In Prepaid Assets Related Terms

Thank you for viewing the detailed overview of Marinus Pharmaceuticals's Change In Prepaid Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Marinus Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Marinus Pharmaceuticals Inc (LTS:0JYL) » Definitions » Change In Prepaid Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

100 Matsonford Road, Suite 500, 5 Radnor Corporate Center, Radnor, PA, USA, 19087

Website

https://www.marinuspharma.com

Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychiatric therapeutics. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19-RE.

Marinus Pharmaceuticals Headlines

No Headlines